Tech Company Financing Transactions
AurKa Pharma Funding Round
AurKa Pharma closed a financing round on 9/19/2016. Investors included TVM Capital.
Transaction Overview
Company Name
Announced On
9/19/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
TVM Capital (Luc Marengere)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Montréal QC, H1A
Canada
Montréal QC, H1A
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans to begin clinical development in Q3-2017.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Caroline Fortier
Browse more venture capital transactions:
Prev: 9/19/2016: LifeDojo venture capital transaction
Next: 9/20/2016: Grab venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs